# Dapagliflozin

## Forxiga 10mg

| 藥物代碼 | OFOR |
| :--- | :--- |
| 適應症 | Type 2 diabetes mellitus. Heart failure to reduce risk of cardiovascular death and hospitalization. |
| 副作用 | CommonRenal: Urinary tract infectious disease \(4.3% to 5.7% \)Reproductive: Female genital infection \(6.9% to 8.4% \)Respiratory: Nasopharyngitis \(6.3% to 6.6% \)SeriousCardiovascular: HypotensionEndocrine metabolic: Diabetic ketoacidosis \(0.3% \), HypoglycemiaImmunologic: Hypersensitivity reaction \(Severe\) \(0.3% \)Renal: Acute injury of kidney, Pyelonephritis, Sepsis due to urinary tract infectionReproductive: Fournier's gangrene, Genital infection \(4.8% to 5.7% \) |
| 禁忌 | Dialysis. Serious hypersensitivity reaction \(eg, anaphylactic reaction or angioedema\) to dapagliflozin. Renal impairment estimated GFR less than 30 mL/min/1.73 m\(2\) in type 2 diabetes. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Monotherapy & add-on combination therapy 10 mg once daily. Combination w/ insulin or insulin secretagogue Lower dose of insulin or insulin secretagogue may be considered. Initial combination therapy 10 mg dapagliflozin + 500 mg metformin once daily. Severe hepatic impairment Initially 5 mg, may be increased to 10 mg if well tolerated. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity 無\(很少\)資料 - 避免使用 |
| 附帶說明 | Micromedex: 懷孕: C 哺乳:Micromedex: Infant risk cannot be ruled out. |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

